About Haxea

Haxea creates breakthrough technologies through innovative research and development. From Internet-of-Things devices that monitor animal health to tailor-made autogenous vaccines, we rethink technologies to keep you, your animals and your environment safe, promoting better and healthier lives and a more sustainable world.

Haxea is part of the Ipafarma Group, a group which researches, develops, manufactures and delivers pharmaceutical and sanitary technologies to globallly-leading names such as Zoetis, MSD, Boehringer Ingelheim, Virbac, Elanco and Ceva.